Related Experiment Videos
[The characteristics of the bacterial flora in patients with interstitial lung diseases]
Abstract:
The paper deals with a possible contribution of microorganisms to the development of interstitial pulmonary diseases (IPD). An examination was made of 57 patients who were in terms of nosological entities were divided into 3 groups: 1) patients with fibrotic alveolitis; 2) those with pulmonary sarcoidosis, and 3) those with histiocytosis X. All patients underwent general clinical examinations, microbiological studies of bronchial contents, mainly bronchial swabs. Based on the examinations and studies, it may be concluded that the infectious component is not the leading predictor of IPD development. However, it should be borne in mind that some patients, those with pulmonary sarcoidosis in particular, have a pneumococcal infectious process.
Insights
Microorganisms are not the primary cause of interstitial pulmonary diseases (IPD). However, some patients, especially those with pulmonary sarcoidosis, may experience pneumococcal infections.
Area of Science:
- Pulmonary Medicine
- Microbiology
- Immunology
Context:
- Investigates the role of microorganisms in interstitial pulmonary diseases (IPD).
- Examines 57 patients diagnosed with fibrotic alveolitis, pulmonary sarcoidosis, and histiocytosis X.
- Includes clinical examinations and microbiological analysis of bronchial contents.
Purpose:
- To determine the contribution of microbial agents to the pathogenesis of interstitial pulmonary diseases.
- To assess the prevalence of infectious processes in patients with different IPD classifications.
Summary:
- Microbiological studies of bronchial contents were performed on 57 patients with IPD.
- Findings indicate that the infectious component is not the leading factor in IPD development.
- A pneumococcal infectious process was noted in a subset of patients, particularly those with pulmonary sarcoidosis.
Impact:
- Suggests that while not the primary driver, microbial infections can be a complicating factor in specific IPD cases.
- Highlights the need for considering infectious etiologies in the management of pulmonary sarcoidosis.
- Provides insights into the multifactorial nature of interstitial pulmonary diseases.